L-048-2015

Agreement ID
L-048-2015
Lead IC
NCI
Exclusivity
Nonexclusive
External Party
PDS Biotechnology Corporation
Fiscal Year
2021
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-4006     MUC-1 Tumor Antigen Agonist Epitopes for Enhancing T-cell Responses to Human Tumors
TAB-5083     Identification and Characterization of HLA-A24 Agonist Epitopes of MUC1 Oncoprotein